Home » Topics » Regulatory

Regulatory
RSS

FDA approves palonosetron for CINV

July 29, 2003

CPMP issues positive opinion for Bondronat for metastatic bone disease

July 29, 2003

Diovan approved in Switzerland for ACE inhibitor-intolerant heart failure patients

July 29, 2003

Enbrel becomes the first FDA-approved biologic for ankylosing spondylitis

July 28, 2003

Zyvox approved for diabetic foot infections

July 28, 2003

Sweden is the first to approve transplant drug Certican

July 25, 2003

Manufacturing approval granted for pitavastatin

July 23, 2003

New European label for Pegasys reflects new genotype data

July 22, 2003

New low doses of Premarin approved for prevention of postmenopausal osteoporosis

July 21, 2003

Keppra oral solution approved for epilepsy

July 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...